<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Relationships between rhinosinusitis and asthma
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Relationships between rhinosinusitis and asthma
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Relationships between rhinosinusitis and asthma
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen F Kemp, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Richard D deShazo, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jonathan Corren, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Anna M Feldweg, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Feb 17, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Asthma and allergic rhinitis (rhinosinusitis) often coexist and may represent similar disease entities (one airway hypothesis) [
         <a href="#rid1">
          1,2
         </a>
         ]. There is also a strong link between asthma and bacterial rhinosinusitis, viral upper respiratory infections (acute viral rhinosinusitis), and nasal polyposis.
        </p>
        <p>
         Allergic rhinitis is almost ubiquitous in patients with allergic asthma [
         <a href="#rid3">
          3-7
         </a>
         ]. Position papers on allergic rhinitis generated at international workshops in collaboration with the World Health Organization [
         <a href="#rid8">
          8-11
         </a>
         ] and endorsed by the American Academy of Allergy, Asthma, and Immunology and by numerous other professional organizations internationally have supported this view.
        </p>
        <p>
         Rhinitis is defined as the presence of sneezing, rhinorrhea (anterior and posterior), nasal congestion, and/or nasal itching arising from irritation and inflammation of the nasal passages. Rhinosinusitis describes disorders affecting both the nasal passages and paranasal sinuses. Symptoms of sinus involvement include nasal congestion, posterior nasal drainage, facial pressure and pain, headache, fatigue, and reduced sense of smell.
        </p>
        <p>
         In most instances, the term "rhinosinusitis" is preferred to "sinusitis" since inflammation of the sinuses rarely occurs without concurrent inflammation of the nasal mucosa. However, rhinitis can occur without sinusitis. Patients with environmental allergies, especially seasonal (eg, pollens), can have rhinitis alone. In contrast, patients with perennial symptoms, usually associated with sensitization to indoor allergens (eg, dust mites, pet danders, fungi), often have prominent nasal congestion and posterior drainage and may be more predisposed to sinus mucosal involvement.
        </p>
        <p>
         This topic reviews the epidemiologic, physiologic, and therapeutic evidence that supports the one airway hypothesis. Allergic rhinitis, acute and chronic rhinosinusitis, and asthma are covered in detail separately in numerous topics. (See
         <a class="medical medical_review" href="/z/d/html/7533.html" rel="external">
          "An overview of rhinitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7530.html" rel="external">
          "Pathogenesis of allergic rhinitis (rhinosinusitis)"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7528.html" rel="external">
          "Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6871.html" rel="external">
          "Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/522.html" rel="external">
          "Pathogenesis of asthma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/83012.html" rel="external">
          "Uncomplicated acute sinusitis and rhinosinusitis in adults: Treatment"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rhinitis occurs in 75 to 90 percent of adult subjects with allergic asthma and 80 percent of those with nonallergic asthma [
         <a href="#rid12">
          12
         </a>
         ]. Conversely, asthma occurs in 25 to 50 percent of individuals with rhinitis. Adults with perennial rhinitis are more likely to have asthma than those without rhinitis [
         <a href="#rid13">
          13
         </a>
         ]. The odds of developing asthma are 8-fold higher in patients with allergic rhinitis and almost 12-fold higher in subjects with nonallergic rhinitis.
        </p>
        <p>
         Similar data are observed in children [
         <a href="#rid3">
          3,6,14,15
         </a>
         ]. In a prospective study of over 600 urban children and adolescents with asthma, 94 percent had a diagnosis by questionnaire of one of five phenotypic forms of rhinitis [
         <a href="#rid3">
          3
         </a>
         ]. Previous estimates of rhinitis in the general population across all ages have ranged from 10 to 40 percent. The children in this study with perennial allergic rhinitis with seasonal exacerbations had the most severe rhinitis symptoms and were more likely to have difficult-to-control asthma and rhinitis. The prevalence of rhinitis in the general population is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7533.html" rel="external">
          "An overview of rhinitis"
         </a>
         .)
        </p>
        <p>
         The Copenhagen Allergy Study further illustrates the close relationship between rhinitis and asthma [
         <a href="#rid6">
          6
         </a>
         ]. This population-based study examined the prevalence of allergic rhinitis and allergic asthma in 700 subjects aged 15 to 69 years at two time points eight years apart. Diagnosis of allergy was based upon allergic respiratory symptoms and in vitro-specific immunoglobulin (Ig)E testing. Findings were as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         All 52 subjects with allergic asthma to pollen had concomitant allergic rhinitis to pollen at the second time point. Twenty-eight of these subjects were new cases. All had allergic rhinitis to pollen at baseline or had developed allergic rhinitis to pollen at follow-up.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Similarly, allergic rhinitis to animals and to dust mites was present in all subjects with allergic asthma to those respective allergens.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          TRIGGERS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The same agents can trigger both rhinitis (rhinosinusitis) and asthma. These include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allergens
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          Aspirin
         </a>
         and other cyclooxygenase 1-inhibiting nonsteroidal antiinflammatory drugs
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Irritants
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infections (viral and bacterial)
        </p>
        <p>
        </p>
        <p>
         As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cysteinyl leukotrienes are released into both nasal and bronchial secretions following
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         challenge in patients with aspirin-exacerbated respiratory disease (classically referred to as aspirin triad or "Samter's triad") [
         <a href="#rid9">
          9,16
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/520.html" rel="external">
          "Aspirin-exacerbated respiratory disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Similarly, occupational rhinitis usually precedes occupational asthma. This is true for both high-molecular-weight agents and low-molecular-weight allergens, such as animal proteins [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7529.html" rel="external">
          "Occupational rhinitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/537.html" rel="external">
          "Occupational asthma: Definitions, epidemiology, causes, and risk factors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rhinoviruses are the major cause of the common cold and are also a trigger of acute asthma exacerbations [
         <a href="#rid17">
          17,18
         </a>
         ]. The combined effects of allergen sensitization, exposure to perennial aeroallergens, and viral infection increase the risk of hospitalization for asthma in adults (odds ratio [OR] 8.4, 95% CI 2.1-32.8) [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         More than two-thirds of individuals with asthma have symptoms of rhinosinusitis. Up to 100 percent of adults with severe, glucocorticoid-dependent asthma and up to 90 percent of those with mild-to-moderate asthma have abnormal sinus computed tomography scans [
         <a href="#rid20">
          20
         </a>
         ]. Fifty to 75 percent of children with asthma have abnormal sinus radiographs. Both acute and chronic rhinosinusitis may exacerbate asthma [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          NATURAL HISTORY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Longitudinal studies suggest that both allergic rhinitis with positive allergy skin tests and nonallergic rhinitis are risk factors for development and persistence of asthma [
         <a href="#rid5">
          5,7,21-27
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         One series surveyed 690 individuals as college freshmen and then reevaluated them 23 years later [
         <a href="#rid5">
          5
         </a>
         ]. None of these individuals had a diagnosis of asthma or symptoms compatible with asthma at the time of their first evaluation. However, 162 had a diagnosis of rhinitis. The incidence of asthma over 23 years was 10.5 percent in subjects with rhinitis and 3.6 percent in those without rhinitis. This study suggests that subjects with allergic rhinitis are three times more likely to develop asthma than those without allergic rhinitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The European Community Respiratory Health Survey, a longitudinal, population-based study, found that rhinitis, either allergic or nonallergic, was predictive of the development of adult-onset asthma in 6461 adult subjects without asthma at baseline [
         <a href="#rid24">
          24
         </a>
         ]. The adjusted relative risk of asthma over approximately nine years was 1.63 (95% CI 0.82-3.24) for "atopy only" (positive prick skin tests for one or more allergens; no rhinitis), 2.71 (95% CI 1.64-4.46) for nonallergic rhinitis, and 3.53 (95% CI 2.11-5.91) for allergic rhinitis. Dust mites were the only allergens independently associated with an increased risk of asthma in patients with allergic rhinitis (2.79 [95% CI 1.57-4.96]).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The Tucson Epidemiologic Study of Obstructive Lung Diseases assessed rhinitis as a potential risk factor for asthma [
         <a href="#rid7">
          7
         </a>
         ]. This study compared 173 adults who developed asthma over 10 years with 2177 control subjects who, during the same approximate period, did not have any chronic lower respiratory tract symptoms. They controlled for several confounding variables, including smoking status and concomitant chronic obstructive pulmonary disease. The odds ratio (OR) for developing asthma was 2.59 (95% CI 1.54-4.34) if rhinitis was present and was 6.28 (95% CI 4.01-9.82) if both rhinitis and rhinosinusitis were present. The risk for asthma increased with the persistence or severity of rhinitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A birth cohort study examined risk factors for persistent wheezing at six years of age [
         <a href="#rid21">
          21
         </a>
         ]. Persistent asthma at six years of age was associated with inhalant allergy, with positive skin tests to aeroallergens and rhinitis independent of colds. These continue to be markers of asthma persistence through adolescence and adult life [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          COMPARATIVE ANATOMY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The structure of the airway mucosa is similar in the nose and bronchi. Histologically similar respiratory epithelium extends posteriorly from the nasal septum and lateral walls of the nasal fossa to the nasopharynx, larynx, trachea, bronchi, and bronchioles. However, there are several differences. Keratinized and unkeratinized stratified squamous epithelium are present in the nasal vestibule. Cartilage is found from nasal fossa to the bronchi only. There is no muscle present in the nasal cavity. Only skeletal muscle is present in the nasopharynx and larynx and only smooth muscle in the lower airway.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          AIRWAY INFLAMMATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The mucosal cellular infiltrates that characterize rhinosinusitis and asthma are similar (eg, eosinophils, mast cells, macrophages, and T cells). In addition, the same proinflammatory mediators are present in both nasal and bronchial mucosa (eg, histamine; leukotrienes; interleukin [IL] 4; IL-5; IL-13; granulocyte-macrophage colony-stimulating factor; regulated on activation, normal T cell expressed and secreted [RANTES]; and adhesion molecules) [
         <a href="#rid9">
          9
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nasal challenge with allergen can result in bronchial inflammation in patients with allergic rhinitis but no clinical signs of asthma [
         <a href="#rid28">
          28,29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Eosinophils are found in higher numbers in both nasal and bronchial biopsies in patients with asthma and allergic rhinitis versus patients with asthma alone [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased eosinophils are seen in nasal mucosa biopsies in patients with asthma, with or without a history of rhinitis [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Individuals with allergic rhinitis but not asthma who respond to segmental
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         bronchoprovocation have increased eosinophils in the lamina propria of the nose [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Computed tomography-graded sinusitis severity is positively associated with sputum and peripheral blood eosinophilia, exhaled nitric oxide levels, and functional residual capacity [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Airway remodeling is an ongoing characteristic of allergic asthma, but a study comparing 46 subjects with severe persistent allergic rhinitis to 17 healthy control subjects observed increased levels of proinflammatory mediators in the rhinitis group but no structural changes or evidence of airway remodeling of nasal tissues compared with the control group [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          AIRWAY HYPERRESPONSIVENESS AND PULMONARY FUNCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Airway hyperresponsiveness (AHR) is common in individuals with allergic rhinitis, even in the absence of a history of wheezing [
         <a href="#rid35">
          35
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Endobronchial challenge in patients with allergic rhinitis induces nasal and bronchial symptoms as well as reductions in nasal and pulmonary function [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with allergic rhinitis have increased bronchial sensitivity to
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         and histamine compared with nonatopic subjects [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with seasonal allergic rhinitis develop seasonal bronchoconstriction that may be unassociated with clinical symptoms [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         One study associated sensitization to aeroallergens with AHR to
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         challenge in seven-year-old children at high risk for atopic disease [
         <a href="#rid39">
          39
         </a>
         ]. In another report, young adults with moderate-to-severe persistent allergic rhinitis and no clinical asthma also demonstrated AHR to methacholine challenge [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with persistent allergic rhinitis and no clinical asthma may nonetheless show significant increases in forced expiratory volume in one second (FEV
         <sub>
          1
         </sub>
         ) from their basal level after treatment with a bronchodilator compared with patients without allergic rhinitis or asthma [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Children with both asthma and allergic rhinitis may have delayed recovery of pulmonary function after an acute asthma exacerbation. Of 57 children consecutively evaluated for moderate/severe asthma exacerbations, 42 percent recovered within seven days. Logistic regression analysis determined that allergic rhinitis (both intermittent and persistent classifications) and severe asthma exacerbation were significant factors in those children whose pulmonary function tests (FEV
         <sub>
          1
         </sub>
         , forced expiratory flow at 25 to 75 percent [FEF25-75], and peak expiratory flow) recovered after more than seven days [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         AHR was greater in patients with both asthma and allergic rhinitis compared with those with asthma alone in another study [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a study of 605 nonasthmatic adult patients with allergic rhinitis, 8 percent had abnormal FEV
         <sub>
          1
         </sub>
         , 25 percent had reduced FEF25-75, and 65 percent had spirometric improvement after bronchodilator [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          INTERACTIONS BETWEEN THE UPPER AND LOWER AIRWAYS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Postulated mechanisms through which the upper and lower airway may interact include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neural interaction (nasal bronchial reflex)
         </strong>
         –
         <strong>
         </strong>
         Animal studies demonstrate reflexes arising from receptor sites in the nose and nasopharynx. These reflexes are mediated by the afferent sensory components of the trigeminal and glossopharyngeal nerves and the efferent bronchoconstrictor fibers of the vagus nerve.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Disturbance of nasal mucosa conditioning (warming and humidification) of the air entering the respiratory tree
         </strong>
         –
         <strong>
         </strong>
         Air warming and humidification are the basic functions of the nasal airway and sinuses. Nasal breathing appears to have a protective effect on exercise-induced bronchospasm. Exercise treadmill tests were conducted with 12 children with mild-to-moderate asthma who were instructed to breathe only through their nose, only through their mouth, or breathe "naturally" (resulted in oral breathing in most patients) [
         <a href="#rid45">
          45
         </a>
         ]. Spontaneous breathing during the exercise challenge resulted in bronchoconstriction, with a decrease in FEV
         <sub>
          1
         </sub>
         . Oral breathing exaggerated the airway hyperreactivity, and nasal breathing abrogated the bronchoconstrictive response. A study of eight adult females with asymptomatic mild asthma demonstrated a slight, progressive decrease in FEV
         <sub>
          1
         </sub>
         over a one-hour period during exclusive oral breathing [
         <a href="#rid46">
          46
         </a>
         ]. Patients also perceived increased difficulty in breathing, and three patients experienced coughing/wheezing after oral breathing. Similar findings were not seen with enforced nasal breathing in the same subjects.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Effects of nitric oxide on both upper and lower airways
         </strong>
         –
         <strong>
         </strong>
         Nitric oxide is formed in multiple cell types by various mechanisms. It serves a protective function. It has strong antiviral and bacteriostatic activity, bronchodilatory effects, and modulatory effects on lower airway responsiveness. In addition, it improves oxygenation. Decreased nitric oxide levels are found in patients with inflammatory conditions, such as chronic rhinosinusitis with or without nasal polyposis [
         <a href="#rid4">
          4
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/542.html" rel="external">
          "Exhaled nitric oxide analysis and applications"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Irritant and inflammatory effects of nasal secretions directly draining into the lower airway, including particles and irritants entrapped in the mucociliary blanket
         </strong>
         –
         <strong>
         </strong>
         Studies in a rabbit model of acute rhinosinusitis provided strong evidence that drainage of nasal inflammatory mediators into the lung may precipitate asthma [
         <a href="#rid47">
          47
         </a>
         ]. There is evidence that pharyngeal aspiration occurs in healthy humans as well as in those with decreased consciousness [
         <a href="#rid48">
          48
         </a>
         ]. However, one study in which radioactively labeled technetium was injected into the maxillary sinuses of subjects with chronic rhinosinusitis and moderate-to-severe asthma failed to detect radioactive material in the lung fields despite the ability to trace it in the gastrointestinal tract [
         <a href="#rid49">
          49
         </a>
         ]. Some investigators have countered that substances produced during allergic reactions can enter the gaseous phase, become aerosolized, and disseminate throughout the lower respiratory tract, thus potentially producing bronchoprovocation [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Systemic propagation of inflammation via effects of mediators and inflammatory cells
         </strong>
         –
         <strong>
         </strong>
         Systemic propagation of inflammation may be a principal connection between the upper and lower airways in patients with allergic respiratory disease. Studies suggest that allergic airway inflammation leads to recruitment of eosinophils into the systemic circulation, which then leads to inflammation of respiratory mucosa not exposed to the culprit allergen [
         <a href="#rid28">
          28,50
         </a>
         ]. Specifically, allergen provocation can lead to inflammatory cell production in the bone marrow [
         <a href="#rid51">
          51
         </a>
         ]. The systemic increase in inflammatory cells can also be detected outside of the airway. Patients with asthma and allergic rhinitis have increased numbers of eosinophils, mast cells, and T cells in duodenal biopsies [
         <a href="#rid52">
          52
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          CLINICAL IMPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The relationship between upper and lower airway disease has clinical relevance. Patients with chronic or recurrent rhinosinusitis should be evaluated for asthma, including pulmonary function studies with bronchodilator if indicated. Patients with persistent asthma should be questioned for symptoms suggestive of rhinitis and acute or chronic rhinosinusitis. Upper airway disease is thought to aggravate or cause lower airway disease, and treatment of upper airway disease can improve lower airway disease [
         <a href="#rid9">
          9,11
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment of allergic rhinitis with intranasal glucocorticoids can prevent or improve asthma symptoms and lower airway hyperresponsiveness (AHR) [
         <a href="#rid53">
          53
         </a>
         ]. Two large, retrospective studies evaluated more than 25,000 subjects and found that intranasal glucocorticoids decrease emergency department visits and hospitalizations for asthma in a dose-dependent manner [
         <a href="#rid54">
          54,55
         </a>
         ]. However, no change was seen in pulmonary function, sputum eosinophils, or
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         responsiveness in another study in which patients with asthma were treated with intranasal glucocorticoids [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of 18 trials concluded that the favorable effects of intranasal glucocorticoids on asthma outcomes were most prominent in patients with asthma and allergic rhinitis who did not also use orally inhaled glucocorticoids [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Oral H1 antihistamines also lower the rates of asthma-related emergency department visits and hospitalizations [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Leukotriene modifiers are effective in controlling symptoms of mild-to-moderate asthma and seasonal allergic rhinitis [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Allergen immunotherapy reduces the progression to asthma in children and adults with allergic rhinoconjunctivitis [
         <a href="#rid60">
          60-66
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/361.html" rel="external">
          "Subcutaneous immunotherapy (SCIT) for allergic rhinoconjunctivitis and asthma: Indications and efficacy", section on 'Prevention of asthma'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="10251" href="/z/d/drug information/10251.html" rel="external">
          Omalizumab
         </a>
         (humanized anti-IgE) is effective in treating patients with moderate-to-severe allergic asthma and is also effective in treating patients with seasonal and perennial allergic rhinitis [
         <a href="#rid67">
          67
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other biologics (eg,
         <a class="drug drug_general" data-topicid="105352" href="/z/d/drug information/105352.html" rel="external">
          mepolizumab
         </a>
         and
         <a class="drug drug_general" data-topicid="107564" href="/z/d/drug information/107564.html" rel="external">
          reslizumab
         </a>
         , both humanized monoclonal anti-interleukin [IL] 5) have efficacy in treating patients with eosinophilic asthma and nasal polyposis [
         <a href="#rid68">
          68-71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiple studies have examined whether surgical treatment of rhinosinusitis may improve asthma, but high-quality evidence is lacking [
         <a href="#rid72">
          72-74
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          One airway hypothesis
         </strong>
         – Asthma and rhinosinusitis often coexist and likely represent a spectrum of the same disease entity. Rhinitis occurs in 75 to 90 percent of adult subjects with asthma, and asthma occurs in 25 to 50 percent of individuals with rhinitis. The upper and lower airways are contiguous and have anatomic and physiologic similarities. In addition, the cellular infiltrates and inflammatory mediators present in rhinitis and asthma are similar, and both disorders have the same triggers. (See
         <a class="local">
          'Epidemiology'
         </a>
         above and
         <a class="local">
          'Comparative anatomy'
         </a>
         above and
         <a class="local">
          'Airway inflammation'
         </a>
         above and
         <a class="local">
          'Triggers'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rhinitis is a risk factor for asthma
         </strong>
         – Longitudinal studies suggest that both allergic rhinitis with positive allergy skin tests and nonallergic rhinitis are risk factors for development and persistence of asthma in children and adults. (See
         <a class="local">
          'Natural history'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Interactions between the upper and lower airway
         </strong>
         – Postulated mechanisms through which the upper and lower airway may interact include the nasal bronchial reflex, disturbance of nasal mucosa conditioning, nitric oxide effects, drainage of irritant and inflammatory material, and systemic propagation of inflammation. (See
         <a class="local">
          'Interactions between the upper and lower airways'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical implications
         </strong>
         – Patients with persistent asthma should be evaluated for rhinitis and rhinosinusitis because detection and treatment of nasal disease improves asthma. (See
         <a class="local">
          'Clinical implications'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Slavin RG. The upper and lower airways: the epidemiological and pathophysiological connection. Allergy Asthma Proc 2008; 29:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberger PA. Allergic rhinitis and asthma connection: treatment implications. Allergy Asthma Proc 2008; 29:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Togias A, Gergen PJ, Hu JW, et al. Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes. J Allergy Clin Immunol 2019; 143:1003.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Togias A. Rhinitis and asthma: evidence for respiratory system integration. J Allergy Clin Immunol 2003; 111:1171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994; 15:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Linneberg A, Henrik Nielsen N, Frølund L, et al. The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study. Allergy 2002; 57:1048.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002; 109:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bousquet J, Lockey R, Malling HJ, et al. Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998; 81:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108:S147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 Suppl 86:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126:466.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sibbald B, Rink E. Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history. Thorax 1991; 46:895.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leynaert B, Bousquet J, Neukirch C, et al. Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999; 104:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shamssain MH, Shamsian N. Prevalence and severity of asthma, rhinitis, and atopic eczema in 13- to 14-year-old schoolchildren from the northeast of England. Ann Allergy Asthma Immunol 2001; 86:428.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sichletidis L, Chloros D, Tsiotsios I, et al. The prevalence of allergic asthma and rhinitis in children of Polichni, Thessaloniki. Allergol Immunopathol (Madr) 2004; 32:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laidlaw TM, Boyce JA. Updates on immune mechanisms in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2023; 151:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heymann PW, Platts-Mills TA, Johnston SL. Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults. Pediatr Infect Dis J 2005; 24:S217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Staudacher AG, Stevens WW. Sinus Infections, Inflammation, and Asthma. Immunol Allergy Clin North Am 2019; 39:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Green RM, Custovic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002; 324:763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bresciani M, Paradis L, Des Roches A, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol 2001; 107:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oswald H, Phelan PD, Lanigan A, et al. Outcome of childhood asthma in mid-adult life. BMJ 1994; 309:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Plaschke PP, Janson C, Norrman E, et al. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med 2000; 162:920.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008; 372:1049.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Nieuwenhof L, Schermer T, Bosch Y, et al. Is physician-diagnosed allergic rhinitis a risk factor for the development of asthma? Allergy 2010; 65:1049.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol 2007; 120:863.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin PE, Matheson MC, Gurrin L, et al. Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: a prospective cohort study over 4 decades. J Allergy Clin Immunol 2011; 127:1473.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonay M, Neukirch C, Grandsaigne M, et al. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Allergy 2006; 61:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pelikan Z. Asthmatic response induced by nasal challenge with allergen. Int Arch Allergy Immunol 2009; 148:330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chanez P, Vignola AM, Vic P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999; 159:588.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaga M, Lambrou P, Papageorgiou N, et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000; 30:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braunstahl GJ, Kleinjan A, Overbeek SE, et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000; 161:2051.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ten Brinke A, Grootendorst DC, Schmidt JT, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 2002; 109:621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eifan AO, Orban NT, Jacobson MR, Durham SR. Severe Persistent Allergic Rhinitis. Inflammation but No Histologic Features of Structural Upper Airway Remodeling. Am J Respir Crit Care Med 2015; 192:1431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arshad SH, Kurukulaaratchy RJ, Fenn M, et al. Rhinitis in 10-year-old children and early life risk factors for its development. Acta Paediatr 2002; 91:1334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Townley RG, Ryo UY, Kolotkin BM, Kang B. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol 1975; 56:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. Thorax 1984; 39:912.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gerblich AA, Schwartz HJ, Chester EH. Seasonal variation of airway function in allergic rhinitis. J Allergy Clin Immunol 1986; 77:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tepas EC, Litonjua AA, Celedón JC, et al. Sensitization to aeroallergens and airway hyperresponsiveness at 7 years of age. Chest 2006; 129:1500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cirillo I, Pistorio A, Tosca M, Ciprandi G. Impact of allergic rhinitis on asthma: effects on bronchial hyperreactivity. Allergy 2009; 64:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ciprandi G, Cirillo I, Pistorio A, et al. Impact of allergic rhinitis on asthma: effects on bronchodilation testing. Ann Allergy Asthma Immunol 2008; 101:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yilmaz O, Bakirtas A, Ertoy Karagol HI, et al. Allergic rhinitis may impact the recovery of pulmonary function tests after moderate/severe asthma exacerbation in children. Allergy 2014; 69:652.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen JW, Thomsen SF, Nolte H, Backer V. Rhinitis: a complication to asthma. Allergy 2010; 65:883.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ciprandi G, Signori A, Tosca MA, Cirillo I. Spirometric abnormalities in patients with allergic rhinitis: Indicator of an "asthma march"? Am J Rhinol Allergy 2011; 25:e181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shturman-Ellstein R, Zeballos RJ, Buckley JM, Souhrada JF. The beneficial effect of nasal breathing on exercise-induced bronchoconstriction. Am Rev Respir Dis 1978; 118:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hallani M, Wheatley JR, Amis TC. Enforced mouth breathing decreases lung function in mild asthmatics. Respirology 2008; 13:553.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brugman SM, Larsen GL, Henson PM, et al. Increased lower airways responsiveness associated with sinusitis in a rabbit model. Am Rev Respir Dis 1993; 147:314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 1978; 64:564.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bardin PG, Van Heerden BB, Joubert JR. Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis. J Allergy Clin Immunol 1990; 86:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braunstahl GJ, Overbeek SE, Kleinjan A, et al. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001; 107:469.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denburg JA, Sehmi R, Saito H, et al. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol 2000; 106:S242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallaert B, Desreumaux P, Copin MC, et al. Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma. J Exp Med 1995; 182:1897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nair A, Vaidyanathan S, Clearie K, et al. Steroid sparing effects of intranasal corticosteroids in asthma and allergic rhinitis. Allergy 2010; 65:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adams RJ, Fuhlbrigge AL, Finkelstein JA, Weiss ST. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Immunol 2002; 109:636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dahl R, Nielsen LP, Kips J, et al. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy 2005; 60:875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lohia S, Schlosser RJ, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy 2013; 68:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corren J, Manning BE, Thompson SF, et al. Rhinitis therapy and the prevention of hospital care for asthma: a case-control study. J Allergy Clin Immunol 2004; 113:415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 2000; 105:917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Möller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002; 109:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Niggemann B, Jacobsen L, Dreborg S, et al. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy 2006; 61:855.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114:851.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polosa R, Al-Delaimy WK, Russo C, et al. Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study. Respir Res 2005; 6:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Passalacqua G, Durham SR, Global Allergy and Asthma European Network. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 2007; 119:881.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007; 62:943.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmitt J, Schwarz K, Stadler E, Wüstenberg EG. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: Results from a large retrospective cohort study. J Allergy Clin Immunol 2015; 136:1511.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 2013; 131:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009; 360:973.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 2011; 128:989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gevaert P, Lang-Loidolt D, Lackner A, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 2006; 118:1133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castro M, Mathur S, Hargreave F, et al. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 2011; 184:1125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsao CH, Chen LC, Yeh KW, Huang JL. Concomitant chronic sinusitis treatment in children with mild asthma: the effect on bronchial hyperresponsiveness. Chest 2003; 123:757.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: a practice parameter update. Ann Allergy Asthma Immunol 2014; 113:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rix I, Håkansson K, Larsen CG, et al. Management of chronic rhinosinusitis with nasal polyps and coexisting asthma: A systematic review. Am J Rhinol Allergy 2015; 29:193.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 7536 Version 13.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19173781" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The upper and lower airways: the epidemiological and pathophysiological connection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19173782" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Allergic rhinitis and asthma connection: treatment implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30213627" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12789212" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Rhinitis and asthma: evidence for respiratory system integration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8005452" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12359002" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The link between allergic rhinitis and allergic asthma: a prospective population-based study. The Copenhagen Allergy Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11897985" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Rhinitis as an independent risk factor for adult-onset asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9860031" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11707753" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Allergic rhinitis and its impact on asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18331513" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20816182" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1792637" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10452748" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Perennial rhinitis: An independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11345287" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Prevalence and severity of asthma, rhinitis, and atopic eczema in 13- to 14-year-old schoolchildren from the northeast of England.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15087091" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The prevalence of allergic asthma and rhinitis in children of Polichni, Thessaloniki.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36184313" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Updates on immune mechanisms in aspirin-exacerbated respiratory disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16378049" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Role of viral infections, atopy and antiviral immunity in the etiology of wheezing exacerbations among children and young adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31284929" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Sinus Infections, Inflammation, and Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11923159" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11149994" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Rhinosinusitis in severe asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7800004" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Asthma and wheezing in the first six years of life. The Group Health Medical Associates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8038676" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Outcome of childhood asthma in mid-adult life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10988106" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18805333" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Rhinitis and onset of asthma: a longitudinal population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20132162" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Is physician-diagnosed allergic rhinitis a risk factor for the development of asthma?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17825896" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21458851" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Childhood eczema and rhinitis predict atopic but not nonatopic adult asthma: a prospective cohort study over 4 decades.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16364165" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19001793" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Asthmatic response induced by nasal challenge with allergen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9927377" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Comparison between nasal and bronchial inflammation in asthmatic and control subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10792358" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10852787" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11941310" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Chronic sinusitis in severe asthma is related to sputum eosinophilia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26378625" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Severe Persistent Allergic Rhinitis. Inflammation but No Histologic Features of Structural Upper Airway Remodeling.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12578291" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Rhinitis in 10-year-old children and early life risk factors for its development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1206183" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6393416" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3700890" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Seasonal variation of airway function in allergic rhinitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16778267" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Sensitization to aeroallergens and airway hyperresponsiveness at 7 years of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19175597" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Impact of allergic rhinitis on asthma: effects on bronchial hyperreactivity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18681083" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Impact of allergic rhinitis on asthma: effects on bronchodilation testing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24649828" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Allergic rhinitis may impact the recovery of pulmonary function tests after moderate/severe asthma exacerbation in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20121767" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Rhinitis: a complication to asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22186235" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Spirometric abnormalities in patients with allergic rhinitis: Indicator of an "asthma march"?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/677559" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : The beneficial effect of nasal breathing on exercise-induced bronchoconstriction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18494947" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Enforced mouth breathing decreases lung function in mild asthmatics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8430954" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Increased lower airways responsiveness associated with sinusitis in a rabbit model.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/645722" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Pharyngeal aspiration in normal adults and patients with depressed consciousness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2370390" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Absence of pulmonary aspiration of sinus contents in patients with asthma and sinusitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11240947" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11080738" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Systemic aspects of allergic disease: bone marrow responses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7500035" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19804441" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Steroid sparing effects of intranasal corticosteroids in asthma and allergic rhinitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11799366" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11941313" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Intranasal steroids and the risk of emergency department visits for asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15932376" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23590215" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15007339" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Rhinitis therapy and the prevention of hospital care for asthma: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10808172" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11842293" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16792584" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15480326" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16381607" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: a retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17418661" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Allergic rhinitis and its impact on asthma update: allergen immunotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17620073" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26371838" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Allergy immunotherapy for allergic rhinitis effectively prevents asthma: Results from a large retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23021878" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19264686" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Mepolizumab and exacerbations of refractory eosinophilic asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21958585" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17088140" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21852542" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12628875" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Concomitant chronic sinusitis treatment in children with mild asthma: the effect on bronchial hyperresponsiveness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25256029" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Diagnosis and management of rhinosinusitis: a practice parameter update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25975250" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Management of chronic rhinosinusitis with nasal polyps and coexisting asthma: A systematic review.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
